Arthritis Research & Therapy

official impact factor 4.36

Review

Rationale of using different biological therapies in rheumatoid arthritis

Matthias Geyer and Ulf Müller-Ladner*

Arthritis Research & Therapy 2010, 12:214 doi:10.1186/ar3102

No comments have yet been made on this article.

Post a comment